ICU Management & Practice, Volume 18 - Issue 4, 2018


Report of a symposium presented at LIVES 2018: 31st congress of the European Society of Intensive Care Medicine, Paris, France 

Chairs:  Michael Sander, Germany  & Jean-Daniel Chiche, France 

Knowledge and practice in sedation and analgesia in the ICU have advanced greatly in recent years. The risks of delirium and of over-sedation and effect on outcomes are well-known. Simple measures such as protocols and sedation strategies can improve outcomes for patients. Technical advances have enabled the use of new techniques in the operating theatre and promise to improve sedation practice in the ICU.

This symposium discussed sedation and analgesia from expert angles, including medication safety in sedation and analgesia, prescribing and using sedation and analgesia, and concluded with a look to the future of sedation and analgesia in the ICU. 

Safety first: insights from clinical pharmacists 

Rob Shulman (London, UK)

What a difference a drug makes?

Jean-Daniel Chiche (Paris, France)

Good past—better future?

Marc Leone (Marseille, France)

This supplement has been prepared in collaboration with Aspen Pharma.


«« AKI: long-term impact on mortality and renal function


Vancomycin pharmacokinetics in critically ill obese patients »»